← Leaderboards
Peter M Small
Stanford University
$2,125,389
Attributed
$2,125,389
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $264.9K · FY2007–08$500K$375K$250K$125K$0
'07
'08
Funding mix
By agency
NIH$2,125,389 · 5
By mechanism
U01$940,768 · 1
D43$663,801 · 2
R21$488,270 · 1
R03$32,550 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- John C Boothroyd$23,306,146
- Gary K Schoolnik$16,579,521
- Celia Goulding$6,911,519
- Lucy Stuart Tompkins$5,236,586
- Matthew S Bogyo$24,780,518
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisDrug ResistanceEpidemiologyCommunicable Disease TransmissionMicroorganism CultureClinical ResearchMexicoHuman SubjectCommunicable Disease ControlBacterial DnaSputumMicroscopyHuman Population StudyGenetic MappingCooperative StudyGenetic PolymorphismComparativeBaseCollectionAntimicrobialEcologyCollaborationsDrug Development
Grant awards (12)
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis$264,870
R21 · FY2008 · AI · contact PI
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis$223,400
R21 · FY2007 · AI · contact PI
ACTIONS FOR BUILDING CAPACITY IN SUPPORT OF ICIDR PROGRA$100,000
D43 · FY2004 · TW
ACTIONS FOR BUILDING CAPACITY IN SUPPORT OF ICIDR PROGRA$100,000
D43 · FY2003 · TW
TRANSMISSION OF PAUCIBACILLARY AND DRUG RESISTANT TB$281,716
U01 · FY2002 · AI
ACTIONS FOR BUILDING CAPACITY IN SUPPORT OF ICIDR PROGRA$100,000
D43 · FY2002 · TW
TRANSMISSION OF PAUCIBACILLARY AND DRUG RESISTANT TB$372,340
U01 · FY2001 · AI
ACTIONS FOR BUILDING CAPACITY IN SUPPORT OF ICIDR PROGRA$100,000
D43 · FY2001 · TW
TRANSMISSION OF PAUCIBACILLARY AND DRUG RESISTANT TB$286,712
U01 · FY2000 · AI
INTERNATIONAL RESEARCH AND TRAINING IN EMERGING DISEASES$163,801
D43 · FY2000 · TW
ACTIONS FOR BUILDING CAPACITY IN SUPPORT OF ICIDR PROGRA$100,000
D43 · FY2000 · TW
INFECTIVITY OF PAUCIBACILLARY PULMONARY TUBERCULOSIS$32,550
R03 · FY2000 · TW